Innovation Fueled by Collaboration and Regulatory Science

In mid-2015 the Food and Drug Administration’s (FDA) Office of Health Informatics awarded DNAnexus a research and development contract to build precisionFDA, an online, cloud-based platform for sharing genomic information. Since its launch, more than 2,000 members of the next-generation sequencing (NGS) community have contributed to this resource by sharing and comparing biomedical data, software…

Read more Innovation Fueled by Collaboration and Regulatory Science

The U.S. Cancer Moonshot and a Culture of Collaboration

Yesterday, United States Vice President Joe Biden hosted the National Cancer Moonshot Summit. Scientists, oncologists, donors, and patients convened for a daylong conference intended to pick up the pace of research towards curing cancer. Rather than focusing on one specific type of cancer, the conference broadly discussed more than 100 types of cancer; emphasizing strategies…

Read more The U.S. Cancer Moonshot and a Culture of Collaboration

DNAnexus in Real Life: Tackling Precision Medicine Through Real-Time, Multi-Institution Cancer Collaboration

Today, the National Comprehensive Cancer Network (NCCN) announced an unprecedented collaborative breast cancer study in the Journal of National Comprehensive Cancer Network. On the DNAnexus Platform, C. Anthony Blau, MD, Director of the Center for Cancer Innovation and Professor of Medicine at University of Washington in Seattle implemented an innovative approach to clinical research and…

Read more DNAnexus in Real Life: Tackling Precision Medicine Through Real-Time, Multi-Institution Cancer Collaboration